About this Event
Overview of Webinar
There are claims of treatments for many disorders, including Childhood Apraxia of Speech, that are easily recognized as unlikely to be true. However, there are also advertisements by individuals or companies that appear to have a research basis for their claims of benefit. How does a concerned parent or SLP to evaluate the credibility of claims made regarding different treatment methods and materials? This session will discuss the use of science and pseudoscience and how to evaluate levels of evidence for different types of research studies to aid professionals and parents in making informed judgments about trying unproven treatments.
As a result of this Webinar, participants will be able to:
- Describe levels of evidence as one metric for considering claims about treatment for childhood speech-language disorders.
- Identify sources for credible information regarding treatment of childhood speech-language disorders.
Minutes 1 – 20 Defining EBP and levels of evidence
Minutes 21 – 30 Issues in research design and reasons for trying unproven interventions
Minutes 31 – 60 Considerations for evaluating unproven treatments
Minutes 61 – 75 Example of evaluating a treatment approach
Minutes 76 – 80 Summary and resources
Minutes 81 – 90 Questions and Answers
This course is offered for .15 ASHA CEU’s (Intermediate Level, Professional Area)
Registration closes at midnight on February 6, 2015
Ruth Stoeckel, PhD, CCC-SLP, is a clinical speech-language pathologist at Mayo Clinic in Rochester, MN. She has experience working as a clinician and independent consultant in schools, private practice, private rehabilitation agency, and clinical settings. Dr. Stoeckel is the author of ASHA web courses on diagnosis and treatment of CAS. She is on the CASANA Professional Advisory Board and authored the curriculum for CASANA’s intensive training institute on CAS. Dr. Stoeckel has presented both nationally and internationally and has co-authored articles on the topics of CAS and literacy for journals including the Journal of Developmental and Behavioral Pediatrics and Journal of Speech, Language, and Hearing Research.
Disclosure: Dr. Stoeckel is a member of the Professional Advisory Board of the Childhood Apraxia of Speech Association of North America. She receives no compensation as a member of CASANA’s Professional Advisory Board. Dr. Stoeckel receives ongoing compensation for her participation in the production of the CASANA DVD “Early Speech-Language Issues and Late Literacy; Will Slow to Talk Mean Slow to Read?” Dr. Stoeckel also receives compensation for the development of the CASANA Intensive Training Institute curriculum, as well as her participation in the training as faculty member. Dr. Stoeckel is also receiving compensation for this presentation.